Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarina Dathe

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Deutsches Arzteblatt International|January 11, 2020
The Use of Medication in PregnancyKatarina Dathe, Christof Schaefer
European Journal of Clinical Pharmacology|October 25, 2017
Drug safety in pregnancy: the German Embryotox instituteKatarina Dathe, Christof Schaefer
Deutsches Arzteblatt International|April 29, 2020
In ReplyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|June 29, 2016
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox DatabaseKatarina Dathe, Evelin Beck, Christof Schaefer
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Do Major Pharmacovigilance Databases Support Evidence of Second Trimester NSAID and Third Trimester Paracetamol Fetotoxicity?Katarina Dathe, Carolin Benndorf, Simone Bergner, et al.
Scientific Reports|June 14, 2026
Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohortLaura Heineke, Evelin Beck, Reinhold Kreutz, et al.
European Journal of Clinical Pharmacology|July 6, 2019
Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature reviewKatarina Dathe, Stefanie Hultzsch, Lucas William Pritchard, et al.
Human Reproduction (Oxford, England)|April 24, 2020
Ulipristal acetate and pregnancy outcome-an observational studyJenny Katharina Wagner, Katarina Dathe, Christof Schaefer, et al.
American Journal of Medical Genetics. Part A|March 26, 2018
Autosomal dominant Robinow syndrome associated with a novel DVL3 splice mutationMagdalena Danyel, Fanny Kortüm, Katarina Dathe, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 1, 2022
Can non-responding mask or mimic drug effects on pregnancy outcome? Evaluation of case characteristics based on the national Embryotox cohortRegina Stegherr, Evelin Beck, Stefanie Hultzsch, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Deutsches Arzteblatt International|January 11, 2020
The Use of Medication in PregnancyKatarina Dathe, Christof Schaefer
European Journal of Clinical Pharmacology|October 25, 2017
Drug safety in pregnancy: the German Embryotox instituteKatarina Dathe, Christof Schaefer
Deutsches Arzteblatt International|April 29, 2020
In ReplyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|June 29, 2016
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox DatabaseKatarina Dathe, Evelin Beck, Christof Schaefer
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Do Major Pharmacovigilance Databases Support Evidence of Second Trimester NSAID and Third Trimester Paracetamol Fetotoxicity?Katarina Dathe, Carolin Benndorf, Simone Bergner, et al.
Scientific Reports|June 14, 2026
Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohortLaura Heineke, Evelin Beck, Reinhold Kreutz, et al.
European Journal of Clinical Pharmacology|July 6, 2019
Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature reviewKatarina Dathe, Stefanie Hultzsch, Lucas William Pritchard, et al.
Human Reproduction (Oxford, England)|April 24, 2020
Ulipristal acetate and pregnancy outcome-an observational studyJenny Katharina Wagner, Katarina Dathe, Christof Schaefer, et al.
American Journal of Medical Genetics. Part A|March 26, 2018
Autosomal dominant Robinow syndrome associated with a novel DVL3 splice mutationMagdalena Danyel, Fanny Kortüm, Katarina Dathe, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 1, 2022
Can non-responding mask or mimic drug effects on pregnancy outcome? Evaluation of case characteristics based on the national Embryotox cohortRegina Stegherr, Evelin Beck, Stefanie Hultzsch, et al.
Pageof 5